Rich LegacyGlorious Future

The JB story is one of passion and performance. Our humble beginnings more than 4 decades ago, set a strong foundation of principles before performance, and a focus on building quality relationships.

This foundation has seen us achieve a lot of significant milestones: from our first international operations, first accreditations, first products to today being India’s fastest growing pharmaceutical company (IQVIA, FY 2020). Our journey is one of consistent growth and delivering value: to patients, healthcare providers, partners, distributors and all stakeholders.

45 years
1st brick in the foundation laid by late Mr. J.B. Mody by incorporating JB Chemicals & Pharmaceuticals Laboratories (JBCPL)
Introduced the product Metrogyl, that went on to become the ‘gold standard’ in the industry
Forayed into the cardiac segment with the revolutionary product Nicardia
Got publicly listed and expanded from API to Formulations
Iconic product Rantac introduced
Capitalized on the vast Russia & CIS OT market with 2 Brands: Doktor Mom & Rinza.
Received first FDA approval for our Panoli Plant:T10.
Launched the product Cilacar that went on to become a leading brand in cardiology and nephrology.
Made a strategic investment in a company in South Africa called Biotech Laboratories.
Received a silver award from the United States Pharmacopeia (USP) for participation in the Monograph Development & Upgradation Program and preparation and distribution of USP reference substance
Leading private equity firm Kohlberg Kravis Roberts & Co. Inc. (KKR), acquired a controlling stake of JBCPL.
Ranked 28th in the Industry (ORG- IMS) with 5 brands: Rantac (Anti – Peptic Ulcer ant), Metrogyl (Amebicides), Nicardia ( Calcium Channel Blocker) and Cilacar-T featuring in top 300 brands of the Indian pharmaceutical market.